Application 208615
- Type
- ANDA
- Sponsor
- SCINOPHARM TAIWAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 2.5MG/0.5ML | No | No |
| 002 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 5MG/0.4ML | No | No |
| 003 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 7.5MG/0.6ML | No | No |
| 004 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 10MG/0.8ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208615-001 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | |
| A208615-002 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 5MG/0.4ML (5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | |
| A208615-003 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 7.5MG/0.6ML (7.5MG/0.6ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | |
| A208615-004 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 10MG/0.8ML (10MG/0.8ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208615-001 | AP |
| A208615-002 | AP |
| A208615-003 | AP |
| A208615-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML (5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML (7.5MG/0.6ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML (10MG/0.8ML) | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | SOLUTION / SUBCUTANEOUS | AP | 2018-11-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-002 | FONDAPARINUX SODIUM | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-003 | FONDAPARINUX SODIUM | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-004 | FONDAPARINUX SODIUM | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | 2018-11-14 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208615-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208615-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208615-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208615-004 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208615-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208615-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208615-004 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208615-004 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208615-004 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208615-004 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208615-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208615-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-003 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208615-004 | AP | 1 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fondaparinux sodium | FONDAPARINUX SODIUM | Zydus Pharmaceuticals (USA) Inc. | dffbf7c9-495e-4a33-ac76-57b52f014fc2 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 208615 ANDA208615 70710-1515 70710-1514 70710-1517 70710-1516 |
| fondaparinux sodium | FONDAPARINUX SODIUM | Italfarmaco S.p.A | 58789e3d-e5bc-4c2e-a527-495a252fcecd | 2020-10-30 | Boxed warning, Warnings, Adverse reactions | 208615 ANDA208615 11797-156 11797-154 11797-157 11797-155 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 11797-154 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-154 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-154 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-155 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-155 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-155 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-156 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-156 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-156 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-157 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-157 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 11797-157 | fondaparinux sodium | fondaparinux sodium | Italfarmaco S.p.A | ANDA | Current |
| 70710-1514 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1514 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1514 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1514 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1515 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1515 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1515 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1515 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1516 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1516 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1516 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1516 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1517 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1517 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1517 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1517 | fondaparinux sodium | fondaparinux sodium | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |